Cargando…
Upregulation of the heterogeneous nuclear ribonucleoprotein hnRNPA1 is an independent predictor of early biochemical recurrence in TMPRSS2:ERG fusion-negative prostate cancers
Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) is a ubiquitous RNA splicing factor that is overexpressed and prognostically relevant in various human cancer types. To study the impact of hnRNPA1 expression in prostate cancer, we analyzed a tissue microarray containing 17,747 clinical prostate...
Autores principales: | Möller, Katharina, Wecker, Anna Lena, Höflmayer, Doris, Fraune, Christoph, Makrypidi-Fraune, Georgia, Hube-Magg, Claudia, Kluth, Martina, Steurer, Stefan, Clauditz, Till S., Wilczak, Waldemar, Simon, Ronald, Sauter, Guido, Huland, Hartwig, Heinzer, Hans, Haese, Alexander, Schlomm, Thorsten, Weidemann, Sören, Luebke, Andreas M., Minner, Sarah, Bernreuther, Christian, Bonk, Sarah, Marx, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581599/ https://www.ncbi.nlm.nih.gov/pubmed/32417965 http://dx.doi.org/10.1007/s00428-020-02834-4 |
Ejemplares similares
-
Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion
por: Steurer, Stefan, et al.
Publicado: (2019) -
Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer
por: Steurer, Stefan, et al.
Publicado: (2019) -
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer
por: Freytag, Morton, et al.
Publicado: (2020) -
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion
por: Fraune, Christoph, et al.
Publicado: (2020) -
Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer
por: Marx, Andreas, et al.
Publicado: (2021)